GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSFF) » Definitions » EV-to-FCF

OSSFF (Embla Medical hf) EV-to-FCF : 29.18 (As of Jun. 30, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Embla Medical hf's Enterprise Value is $2,682.4 Mil. Embla Medical hf's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was $91.9 Mil. Therefore, Embla Medical hf's EV-to-FCF for today is 29.18.

The historical rank and industry rank for Embla Medical hf's EV-to-FCF or its related term are showing as below:

OSSFF' s EV-to-FCF Range Over the Past 10 Years
Min: 22.72   Med: 45.63   Max: 79.56
Current: 26.9

During the past 13 years, the highest EV-to-FCF of Embla Medical hf was 79.56. The lowest was 22.72. And the median was 45.63.

OSSFF's EV-to-FCF is ranked worse than
51.15% of 391 companies
in the Medical Devices & Instruments industry
Industry Median: 26.09 vs OSSFF: 26.90

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-06-30), Embla Medical hf's stock price is $4.15. Embla Medical hf's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $0.170. Therefore, Embla Medical hf's PE Ratio (TTM) for today is 24.41.


Embla Medical hf EV-to-FCF Historical Data

The historical data trend for Embla Medical hf's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf EV-to-FCF Chart

Embla Medical hf Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.67 41.74 69.25 40.08 33.20

Embla Medical hf Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.66 42.56 34.63 33.20 23.59

Competitive Comparison of Embla Medical hf's EV-to-FCF

For the Medical Devices subindustry, Embla Medical hf's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's EV-to-FCF falls into.


;
;

Embla Medical hf EV-to-FCF Calculation

Embla Medical hf's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2682.443/91.929
=29.18

Embla Medical hf's current Enterprise Value is $2,682.4 Mil.
Embla Medical hf's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $91.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf  (OTCPK:OSSFF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Embla Medical hf's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.15/0.170
=24.41

Embla Medical hf's share price for today is $4.15.
Embla Medical hf's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.170.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Embla Medical hf EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.

Embla Medical hf Headlines

From GuruFocus

Q1 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2025 Embla Medical hf Earnings Call Transcript

By GuruFocus News 04-30-2025

Q2 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Embla Medical hf: Interim Report Q4 2024

By PRNewswire 02-05-2025

Q2 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 10-09-2024

Q1 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 10-30-2024

Q1 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus Research 04-24-2024